- Previous Close
140.82 - Open
140.15 - Bid --
- Ask --
- Day's Range
139.95 - 142.15 - 52 Week Range
99.16 - 161.60 - Volume
184 - Avg. Volume
62,947 - Market Cap (intraday)
-- - Beta (5Y Monthly) 1.26
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Mar 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Wacker Chemie AG, together with its subsidiaries, provides chemical products worldwide. It operates through four divisions: Wacker Silicones, Wacker Polymers, Wacker Biosolutions, and Wacker Polysilicon. The Wacker Silicones division offers silanes, siloxanes, silicone fluids, silicone emulsions, silicone elastomers, silicone resins, and pyrogenic silica. The Wacker Polymers division provides binders and polymeric additives, such as dispersible polymer powder and vinyl acetate-ethylene dispersions, which are used in construction, paper, adhesive, paint, coating, and basic chemical industries. The Wacker Biosolutions division offers customized biotech and catalog products for fine chemicals, such as pharmaceutical proteins, vaccines, cyclodextrins, cysteine, polyvinyl acetate solid resins, and acetylacetone for pharmaceutical actives, food additives, and agrochemicals. The Wacker Polysilicon division produces hyperpure polysilicon for use in semiconductor and solar sectors. Wacker Chemie AG was founded in 1914 and is headquartered in Munich, Germany. Wacker Chemie AG operates as a subsidiary of Dr. Alexander Wacker Familiengesellschaft mbH.
www.wacker.com16,555
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Recent News: 0NR4.L
View MorePerformance Overview: 0NR4.L
Trailing total returns as of 3/11/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0NR4.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0NR4.L
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
2.15%
Return on Assets (ttm)
0.65%
Return on Equity (ttm)
3.11%
Revenue (ttm)
5.77B
Net Income Avi to Common (ttm)
124.3M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
978.6M
Total Debt/Equity (mrq)
39.14%
Levered Free Cash Flow (ttm)
-311.62M